GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol
Authors
Dongyan Cao (ORCID: https://orcid.org/0000-0003-4253-832X)
Jiaxin Yang (ORCID: https://orcid.org/0000-0002-1276-1136)
Qian Liu (ORCID: https://orcid.org/0000-0002-1574-6150)
Mei Yu (ORCID: https://orcid.org/0000-0003-4001-1188)
Huimei Zhou
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
National Key Research and Development Program of China
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol
Dongyan Cao, Jiaxin Yang, Qian Liu, Mei Yu et al.
Citations
12 citations
Journal
Trials
Topics
Endometrial and Cervical Cancer Treatments
Field-Weighted Citation Impact (FWCI)
6.99
article
GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol
Dongyan Cao, Jiaxin Yang, Qian Liu, Mei Yu, Huimei Zhou
article en
12 citations
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 25(1)
Institutions
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking Union Medical College Hospital (CN)
Funders
Peking Union Medical College Hospital, National Key Research and Development Program of China